TITLE

Longer-acting and highly potent chimaeric inhibitors of excessive exocytosis created with domains from botulinum neurotoxin A and B

AUTHOR(S)
WANG, Jiafu; ZURAWSKI, Tomas H.; BODEKER, MacDara O.; MENG, Jianghui; BODDUL, Sanjay; AOKI, K. Roger; DOLLY, J. Oliver
PUB. DATE
May 2012
SOURCE
Biochemical Journal;5/15/2012, Vol. 444 Issue 1, p59
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Various human neurogenic hyper-excitability disorders are successfully treated with type A or B BoNT (botulinum neurotoxin). The BoNT/A complex is widely used because of its longer-lasting benefits; also, autonomic side-effects are more often reported for BoNT/B. To establish if this distinct effect of BoNT/B could be exploited therapeutically, BoNT/A was modified so that it would bind the more abundant BoNT/B acceptor in rodents while retaining its desirable persistent action. The advantageous protease and translocation domain of BoNT/A were recombinantly combined with the acceptor-binding moiety of type B [HC/B (C-terminal half of BoNT/B heavy chain)], creating the chimaera AB. This purified protein bound the BoNT/B acceptor, displayed enhanced capability relative to type A for intraneuronally delivering its protease, cleaved SNAP- 25 (synaptosome-associated protein of 25 kDa) and induced a more prolonged neuromuscular paralysis than BoNT/A in mice. The BA chimaera, generated by substituting HC/A (Cterminal half of BoNT/A heavy chain) into BoNT/B, exhibited an extremely high specific activity, delivered the BoNT/B protease via the BoNT/A acceptor into neurons, or fibroblast-like synoviocytes that lack SNAP-25, cleaving the requisite isoforms of VAMP (vesicle-associated membrane protein). Both chimaeras inhibited neurotransmission in murine bladder smooth muscle. BA has the unique ability to reduce exocytosis from non-neuronal cells expressing the BoNT/A-acceptor and utilising VAMP, but not SNAP-25, in exocytosis.
ACCESSION #
87741323

 

Related Articles

  • A molecular basis underlying differences in the toxicity of botulinum serotypes A and E. Bajohrs, Mark; Rickman, Colin; Binz, Thomas; Davletov, Bazbek // EMBO Reports;Nov2004, Vol. 5 Issue 11, p1090 

    Botulinum neurotoxins (BoNTs) block neurotransmitter release through their specific proteolysis of the proteins responsible for vesicle exocytosis. Paradoxically, two serotypes of BoNTs, A and E, cleave the same molecule, synaptosome-associated protein with relative molecular mass 25K (SNAP-25),...

  • Binding of the complexin N terminus to the SNARE complex potentiates synaptic-vesicle fusogenicity. Mingshan Xue; Craig, Timothy K.; Junjie Xu; Chao, Hsiao-Tuan; Rizo, Josep; Rosenmund, Christian // Nature Structural & Molecular Biology;May2010, Vol. 17 Issue 5, p568 

    Complexins facilitate and inhibit neurotransmitter release through distinct domains, and their function was proposed to be coupled to the Ca2+ sensor synaptotagmin-1 (Syt1). However, the mechanisms underlying complexin function remain unclear. We now uncover an interaction between the complexin...

  • Direct observation of individual endogenous protein complexes in situ by proximity ligation. Söderberg, Ola; Gullberg, Mats; Jarvius, Malin; Ridderstråle, Karin; Leuchowius, Karl-Johan; Jarvius, Jonas; Wester, Kenneth; Hydbring, Per; Bahram, Fuad; Larsson, Lars-Gunnar; Landegren, Ulf // Nature Methods;Dec2006, Vol. 3 Issue 12, p995 

    Cellular processes can only be understood as the dynamic interplay of molecules. There is a need for techniques to monitor interactions of endogenous proteins directly in individual cells and tissues to reveal the cellular and molecular architecture and its responses to perturbations. Here we...

  • Molecular determinants of exocytosis. Bruns, Dieter; Jahn, Reinhard // Pflugers Archiv European Journal of Physiology;Jan2002, Vol. 443 Issue 3, p333 

    Membrane fusion processes occur throughout the cell. Among those, exocytosis of secretory organelles is probably one of the fastest fusion events animal cells can achieve. Structural and functional studies have provided a conceptual framework and a starting point for our mechanistic...

  • Entering neurons: botulinum toxins and synaptic vesicle recycling. Verderio, Claudia; Rossetto, Ornella; Grumelli, Carlotta; Frassoni, Carolina; Montecucco, Cesare; Matteoli, Michela // EMBO Reports;Oct2006, Vol. 7 Issue 10, p995 

    Botulinum toxins are metalloproteases that act inside nerve terminals and block neurotransmitter release through their cleavage of components of the exocytosis machinery. These toxins are used to treat human diseases that are characterized by hyperfunction of cholinergic terminals. Recently,...

  • Light Chain Separated from the Rest of the Type A Botulinum Neurotoxin Molecule Is the Most Catalytically Active Form. Gul, Nizamettin; Smith, Leonard A.; Ahmed, S. Ashraf // PLoS ONE;2010, Vol. 5 Issue 9, p1 

    Botulinum neurotoxins (BoNT) are the most potent of all toxins. The 50 kDa N-terminal endopeptidase catalytic light chain (LC) of BoNT is located next to its central, putative translocation domain. After binding to the peripheral neurons, the central domain of BoNT helps the LC translocate into...

  • Botulinum Neurotoxin D Uses Synaptic Vesicle Protein SV2 and Gangliosides as Receptors. Lisheng Peng; Tepp, William H.; Johnson, Eric A.; Min Dong // PLoS Pathogens;Mar2011, Vol. 7 Issue 3, preceding p1 

    No abstract available.

  • Widespread Sequence Variations in VAMP1 across Vertebrates Suggest a Potential Selective Pressure from Botulinum Neurotoxins. Peng, Lisheng; Adler, Michael; Demogines, Ann; Borrell, Andrew; Liu, Huisheng; Tao, Liang; Tepp, William H.; Zhang, Su-Chun; Johnson, Eric A.; Sawyer, Sara L.; Dong, Min // PLoS Pathogens;Jul2014, Vol. 10 Issue 7, p1 

    Botulinum neurotoxins (BoNT/A-G), the most potent toxins known, act by cleaving three SNARE proteins required for synaptic vesicle exocytosis. Previous studies on BoNTs have generally utilized the major SNARE homologues expressed in brain (VAMP2, syntaxin 1, and SNAP-25). However, BoNTs target...

  • Protein-Protein Interactions in Clathrin Vesicular Assembly: Radial Distribution of Evolutionary Constraints in Interfaces. Gadkari, Rupali A.; Srinivasan, Narayanaswamy // PLoS ONE;Feb2012, Vol. 7 Issue 2, p1 

    In eukaryotic organisms clathrin-coated vesicles are instrumental in the processes of endocytosis as well as intracellular protein trafficking. Hence, it is important to understand how these vesicles have evolved across eukaryotes, to carry cargo molecules of varied shapes and sizes. The...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics